Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.29

Margin Of Safety %

10

Put/Call OI Ratio

0.73

EPS Next Q Diff

-0.35

EPS Last/This Y

8.47

EPS This/Next Y

1.26

Price

237.49

Target Price

274.08

Analyst Recom

1.53

Performance Q

-1.19

Relative Volume

1.12

Beta

0.4

Ticker: BDX




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19BDX223.810.800.9625201
2024-12-20BDX227.810.831.9631312
2024-12-23BDX226.450.880.2325223
2024-12-24BDX226.950.870.1225518
2024-12-26BDX228.130.870.1825509
2024-12-27BDX228.540.860.3126121
2024-12-30BDX226.50.850.3326236
2024-12-31BDX226.880.840.4326433
2025-01-02BDX226.440.850.1926441
2025-01-03BDX228.460.813.7327016
2025-01-06BDX230.860.830.0827257
2025-01-07BDX232.320.790.1528047
2025-01-08BDX234.430.790.0627956
2025-01-09BDX234.430.790.0627956
2025-01-10BDX233.620.750.3028877
2025-01-13BDX236.020.740.5829126
2025-01-14BDX235.810.720.3529099
2025-01-15BDX232.370.712.3829161
2025-01-16BDX236.30.740.1029371
2025-01-17BDX237.340.730.3529521
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19BDX223.8311.9410.314.35
2024-12-20BDX227.7411.9453.314.35
2024-12-23BDX226.4411.9400.414.35
2024-12-24BDX226.9511.9418.214.35
2024-12-26BDX228.1211.9424.914.35
2024-12-27BDX228.5711.9417.614.35
2024-12-30BDX226.5811.9393.614.35
2024-12-31BDX226.7911.9415.814.35
2025-01-02BDX226.5311.9409.514.35
2025-01-03BDX228.4811.9433.314.35
2025-01-06BDX230.7811.9436.514.35
2025-01-07BDX232.2711.9428.814.35
2025-01-08BDX234.4311.9435.814.35
2025-01-09BDX234.4311.9413.014.35
2025-01-10BDX233.6611.9405.314.35
2025-01-13BDX236.1511.9437.714.35
2025-01-14BDX235.8811.9409.914.35
2025-01-15BDX232.4611.9379.914.35
2025-01-16BDX236.1811.9448.914.35
2025-01-17BDX237.4911.9424.714.35
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19BDX-1.530.920.66
2024-12-20BDX-2.080.920.66
2024-12-23BDX-2.040.910.65
2024-12-24BDX-2.040.910.65
2024-12-26BDX-2.070.910.91
2024-12-27BDX-2.080.910.91
2024-12-30BDX-2.070.880.91
2024-12-31BDX-2.070.880.91
2025-01-02BDX-2.070.880.91
2025-01-03BDX-2.080.880.91
2025-01-06BDX-2.060.900.91
2025-01-07BDX-2.060.900.91
2025-01-08BDX-2.080.900.91
2025-01-09BDX-2.080.900.91
2025-01-10BDX-2.230.900.91
2025-01-13BDX-2.230.971.29
2025-01-14BDX-2.230.971.29
2025-01-15BDX-2.230.971.29
2025-01-16BDX-2.230.971.29
2025-01-17BDX-2.230.971.29
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

3.81

Avg. EPS Est. Current Quarter

3

Avg. EPS Est. Next Quarter

3.46

Insider Transactions

-2.23

Institutional Transactions

0.97

Beta

0.4

Average Sales Estimate Current Quarter

5114

Average Sales Estimate Next Quarter

5454

Fair Value

261.7

Quality Score

71

Growth Score

84

Sentiment Score

78

Actual DrawDown %

17.3

Max Drawdown 5-Year %

-29.6

Target Price

274.08

P/E

39.96

Forward P/E

15.11

PEG

4.44

P/S

3.41

P/B

2.65

P/Free Cash Flow

22.4

EPS

5.94

Average EPS Est. Cur. Y​

14.35

EPS Next Y. (Est.)

15.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.55

Relative Volume

1.12

Return on Equity vs Sector %

-12.5

Return on Equity vs Industry %

-3.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

424.7
Becton, Dickinson and Company
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 70000
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
stock quote shares BDX – Becton, Dickinson and Company Stock Price stock today
news today BDX – Becton, Dickinson and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch BDX – Becton, Dickinson and Company yahoo finance google finance
stock history BDX – Becton, Dickinson and Company invest stock market
stock prices BDX premarket after hours
ticker BDX fair value insiders trading